220 related articles for article (PubMed ID: 12851464)
1. Liver gene expression in rats in response to the peroxisome proliferator-activated receptor-alpha agonist ciprofibrate.
Yadetie F; Laegreid A; Bakke I; Kusnierczyk W; Komorowski J; Waldum HL; Sandvik AK
Physiol Genomics; 2003 Sep; 15(1):9-19. PubMed ID: 12851464
[TBL] [Abstract][Full Text] [Related]
2. Gene expression profiling of the PPAR-alpha agonist ciprofibrate in the cynomolgus monkey liver.
Cariello NF; Romach EH; Colton HM; Ni H; Yoon L; Falls JG; Casey W; Creech D; Anderson SP; Benavides GR; Hoivik DJ; Brown R; Miller RT
Toxicol Sci; 2005 Nov; 88(1):250-64. PubMed ID: 16081524
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive gene expression analysis of peroxisome proliferator-treated immortalized hepatocytes: identification of peroxisome proliferator-activated receptor alpha-dependent growth regulatory genes.
Tien ES; Gray JP; Peters JM; Vanden Heuvel JP
Cancer Res; 2003 Sep; 63(18):5767-80. PubMed ID: 14522898
[TBL] [Abstract][Full Text] [Related]
4. Species-specific kinetics and zonation of hepatic DNA synthesis induced by ligands of PPARalpha.
Al Kholaifi A; Amer A; Jeffery B; Gray TJ; Roberts RA; Bell DR
Toxicol Sci; 2008 Jul; 104(1):74-85. PubMed ID: 18375545
[TBL] [Abstract][Full Text] [Related]
5. Microarray analysis of gene expression changes in mouse liver induced by peroxisome proliferator- activated receptor alpha agonists.
Yamazaki K; Kuromitsu J; Tanaka I
Biochem Biophys Res Commun; 2002 Jan; 290(3):1114-22. PubMed ID: 11798191
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor alpha (PPARalpha) activators induce hepatic farnesyl diphosphate synthase gene expression in rodents.
Le Jossic-Corcos C; Pastori GM; Duclos S; Kawabe Y; Pineau T; Bournot P
J Steroid Biochem Mol Biol; 2004 Feb; 88(2):203-11. PubMed ID: 15084352
[TBL] [Abstract][Full Text] [Related]
7. Antral G cells in rats during dosing with a PPAR alpha agonist: a morphometric and immunocytochemical study.
Martinsen TC; Skogaker NE; Bendheim MØ; Waldum HL
Med Electron Microsc; 2003 Mar; 36(1):18-32. PubMed ID: 12658348
[TBL] [Abstract][Full Text] [Related]
8. Less extrahepatic induction of fatty acid beta-oxidation enzymes by PPAR alpha.
Cook WS; Yeldandi AV; Rao MS; Hashimoto T; Reddy JK
Biochem Biophys Res Commun; 2000 Nov; 278(1):250-7. PubMed ID: 11071880
[TBL] [Abstract][Full Text] [Related]
9. Human HepG2 and rat Fao hepatic-derived cell lines show different responses to ciprofibrate, a peroxisome proliferator: analysis by flow cytometry.
Passilly P; Jannin B; Hassell SJ; Latruffe N
Exp Cell Res; 1996 Mar; 223(2):436-42. PubMed ID: 8601421
[TBL] [Abstract][Full Text] [Related]
10. Comitogenicity of eicosanoids and the peroxisome proliferator ciprofibrate in cultured rat hepatocytes.
Hong JT; Glauert HP
J Cell Physiol; 1996 Nov; 169(2):309-19. PubMed ID: 8908198
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiles in rat liver slices exposed to hepatocarcinogenic enzyme inducers, peroxisome proliferators, and 17alpha-ethinylestradiol.
Werle-Schneider G; Wölfelschneider A; von Brevern MC; Scheel J; Storck T; Müller D; Glöckner R; Bartsch H; Bartelmann M
Int J Toxicol; 2006; 25(5):379-95. PubMed ID: 16940010
[TBL] [Abstract][Full Text] [Related]
12. The peroxisome-proliferator-activated receptor alpha agonist ciprofibrate severely aggravates hypercholesterolaemia and accelerates the development of atherosclerosis in mice lacking apolipoprotein E.
Fu T; Kashireddy P; Borensztajn J
Biochem J; 2003 Aug; 373(Pt 3):941-7. PubMed ID: 12713444
[TBL] [Abstract][Full Text] [Related]
13. Induction of the expression of the peroxisome proliferator-activated receptor alpha (PPARalpha) by clofibrate in jerboa tissues.
Amsaguine-Safir S; Bianchi A; Collet P; Huin-Schohn C; Jeanvoine A; Bécuwe P; Krémarik-Bouillaud P; Domenjoud L; Keller JM; Schohn H; Dauça M
Microsc Res Tech; 2003 Jun; 61(2):185-90. PubMed ID: 12740825
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-induced alterations in the expression and modification of rat hepatocyte plasma membrane proteins.
Bartles JR; Khuon S; Lin XH; Zhang LQ; Reddy JK; Rao MS; Isoye ST; Nehme CL; Fayos BE
Cancer Res; 1990 Feb; 50(3):669-76. PubMed ID: 2404574
[TBL] [Abstract][Full Text] [Related]
15. Regulation of human hepatic hydroxysteroid sulfotransferase gene expression by the peroxisome proliferator-activated receptor alpha transcription factor.
Fang HL; Strom SC; Cai H; Falany CN; Kocarek TA; Runge-Morris M
Mol Pharmacol; 2005 Apr; 67(4):1257-67. PubMed ID: 15635043
[TBL] [Abstract][Full Text] [Related]
16. Administration of ciprofibrate to lactating mothers induces PPARalpha-signaling pathway in the liver and kidney of suckling rats.
Fidaleo M; Sartori C
Exp Toxicol Pathol; 2008 Jun; 60(1):33-41. PubMed ID: 18434116
[TBL] [Abstract][Full Text] [Related]
17. Prevention/reversal of choline deficiency-induced steatohepatitis by a peroxisome proliferator-activated receptor alpha ligand in rats.
Rao MS; Papreddy K; Musunuri S; Okonkwo A
In Vivo; 2002; 16(2):145-52. PubMed ID: 12073774
[TBL] [Abstract][Full Text] [Related]
18. Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor alpha.
Cheung C; Akiyama TE; Ward JM; Nicol CJ; Feigenbaum L; Vinson C; Gonzalez FJ
Cancer Res; 2004 Jun; 64(11):3849-54. PubMed ID: 15172993
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells.
Marx N; Duez H; Fruchart JC; Staels B
Circ Res; 2004 May; 94(9):1168-78. PubMed ID: 15142970
[TBL] [Abstract][Full Text] [Related]
20. Formation of 8-hydroxydeoxyguanosine in liver DNA of rats following long-term exposure to a peroxisome proliferator.
Kasai H; Okada Y; Nishimura S; Rao MS; Reddy JK
Cancer Res; 1989 May; 49(10):2603-5. PubMed ID: 2713844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
